Selinexor-d5
Selinexor-d5 (KPT-330-d5) isthe deuterium labeled Selinexor. Selinexor (KPT-330), an analog of KPT-185, is an orally active and selective CRM1 inhibitor[1][2].
Product Specifications
Product Name Alternative
KPT-330-d5
UNSPSC
12352005
Target
CRM1; Isotope-Labeled Compounds
Related Pathways
Membrane Transporter/Ion Channel; Others
Field of Research
Cancer
Smiles
O=C(NNC1=NC([2H])=C([2H])N=C1[2H])/C([2H])=C([2H])\N2N=C(C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)N=C2
Molecular Formula
C17H6D5F6N7O
Molecular Weight
448.34
References & Citations
[1]Etchin J, et al. KPT-330 inhibitor of CRM1 (XPO1) -mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Br J Haematol. 2013 Apr;161 (1) :117-27. |[2]Tai YT, et al. CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. Leukemia. 2014 Jan;28 (1) :155-65.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040097-100 1x 100 µL
Nuclear Membrane (NM97), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472774-500 1x 500 µL
PAX8 (Renal Cell Marker) (PAX8/2774R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470714-100 1x 100 µL
Thymidylate Synthase (TS106), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details